Total assets rose to $874.1M in 2026Q3 with only $33.9M of total debt and a debt-to-equity ratio of 0.11, but the current ratio declined from 2.31 in 2025Q1 to 1.04 and the accumulated deficit of -$914.8M persists against $299.4M of equity.
Hinge Health, Inc. (HNGE) balance sheet — 3-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 |
|---|
| Total Current Assets | 567.86M | 533.9M | 583.45M | 529.88M |
| Cash & Short-Term Investments | 294.65M | 363.86M | 466.57M | 423.36M |
| Cash Only | 211.55M | 208M | 300.79M | 234.95M |
| Short-Term Investments | 83.1M | 155.87M | 165.79M | 188.4M |
| Accounts Receivable | 148.53M | 66.06M | 42.49M | 46.56M |
| Days Sales Outstanding | 51.84 | 41.02 | 39.73 | 58.06 |
| Inventory | 19.19M | 15.64M | 10.87M | 13.29M |
| Days Inventory Outstanding | 70.04 | 48.14 | 44.19 | 49.23 |
| Other Current Assets | 46.6M | 57.41M | 39.59M | 32.31M |
| Total Non-Current Assets | 306.22M | 210.86M | 89.81M | 92.65M |
| Property, Plant & Equipment | 47.31M | 17.35M | 16.99M | 22.48M |
| Fixed Asset Turnover | 32.12x | 33.88x | 22.98x | 13.02x |
| Goodwill | 113.03M | 64.1M | 61.61M | 61.61M |
| Intangible Assets | 68.33M | 2.51M | 1.81M | 2.19M |
| Long-Term Investments | 347.23M | 113.17M | 0 | 0 |
| Other Non-Current Assets | 18.01M | 13.73M | 9.41M | 6.38M |
| Total Assets | 874.08M | 744.76M | 673.26M | 622.53M |
| Asset Turnover | 1.01x | 0.79x | 0.58x | 0.47x |
| Asset Growth % | 45.36% | 10.62% | 8.15% | - |
| Total Current Liabilities | 544.71M | 362.41M | 249.3M | 184.16M |
| Accounts Payable | 80.82M | 0 | 0 | 0 |
| Days Payables Outstanding | 64.61 | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 1.52B | 300.86M | 217.63M | 140.47M |
| Other Current Liabilities | 0 | 11.46M | 4.16M | 6.37M |
| Current Ratio | 1.04x | 1.47x | 2.34x | 2.88x |
| Quick Ratio | 1.01x | 1.43x | 2.30x | 2.81x |
| Cash Conversion Cycle | 57.27 | - | - | - |
| Total Non-Current Liabilities | 29.95M | 3.82M | 7.26M | 11.1M |
| Long-Term Debt | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 37.34M | 3.82M | 7.26M | 11.1M |
| Deferred Tax Liabilities | 795K | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | 574.66M | 366.23M | 256.56M | 195.25M |
| Total Debt | 33.88M | 8.04M | 11.07M | 15.73M |
| Net Debt | -177.68M | -199.96M | -289.71M | -219.22M |
| Debt / Equity | 0.11x | 0.02x | 0.03x | 0.04x |
| Debt / EBITDA | 0.22x | - | - | - |
| Net Debt / EBITDA | -1.14x | - | - | - |
| Interest Coverage | - | - | - | - |
| Total Equity | 299.42M | 378.54M | 416.7M | 427.28M |
| Equity Growth % | -72.6% | -9.16% | -2.48% | - |
| Book Value per Share | 3.46 | 4.63 | 5.34 | 5.48 |
| Total Shareholders' Equity | 299.42M | 378.54M | 416.7M | 427.28M |
| Common Stock | 0 | 0 | 0 | 0 |
| Retained Earnings | -914.78M | -1.05B | -522.74M | -510.8M |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Accumulated OCI | -921K | -20K | 68K | 60K |
| Minority Interest | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying HNGE stock.
As of 2025, Hinge Health, Inc. (HNGE) had total assets of $744.8M including $533.9M in current assets.
Hinge Health, Inc. (HNGE) carries total debt of $8.0M, offset by $363.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Hinge Health, Inc. (HNGE) has total shareholders' equity (book value) of $378.5M ($4.63 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Hinge Health, Inc. (HNGE) reported a current ratio of 1.47x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Accumulated deficit persists
Metrics are mathematically derived from official filings.
Balance Sheet Rebuilding Through Equity Growth
According to recent SEC filings, HNGE's total assets rose from $675.5M in 2024Q4 to $874.1M in 2026Q3 while total liabilities climbed more slowly, suggesting the balance sheet is strengthening as the business scales.
The expansion in assets appears driven by cash build and goodwill additions, with goodwill rising from $64.1M to $113.0M over the most recent quarters. Total liabilities have grown alongside deferred revenue, which increased from $217.6M to $459.2M, indicating that much of the liability growth reflects prepaid customer contracts rather than borrowed funds. This pattern may indicate improving balance sheet quality, though investors should monitor whether acquisition activity continues to add goodwill that carries impairment risk.
Minimal Leverage Keeps Refinancing Risk Low
Based on reported figures, HNGE carried only $33.9M of total debt against $211.6M of cash in 2026Q3, leaving a debt-to-equity ratio of 0.11 that is low relative to most of its healthcare technology peers.
Total debt has declined from $11.1M in 2024Q4 to a peak-period range near $5.9M to $9.0M before rising to $33.9M in the latest quarter, which may reflect a newly drawn facility or lease-related obligations that the data does not itemize. Because leverage remains modest, refinancing pressure appears limited, and cash flow durability is not dependent on debt service. The recent step-up in debt warrants confirmation of its composition in the filing footnotes.
Liquidity Cushion Tied to Working Capital
As reported in financial statements, HNGE's current ratio fell from 2.31 in 2025Q1 to 1.04 in 2026Q3, while cash stood at $211.6M, indicating a thinner short-term buffer than the company held a year earlier.
The decline in the current ratio appears largely attributable to rising deferred revenue, which is a current liability that grew to $459.2M, rather than to a deterioration in cash. Cash of $211.6M still provides meaningful coverage of near-term obligations, but the ratio near 1.0 leaves less slack if billing timing or collections shift. Given that operating cash flow has been positive, investors may view this as a working-capital consequence of prepaid contracts rather than a solvency concern, though this interpretation depends on collection performance.
Deep Accumulated Deficit Shapes Equity Base
Based on reported figures, HNGE's retained earnings stood at negative $914.8M in 2026Q3 against total equity of $299.4M, a deficit that reflects years of cumulative losses despite recent profitability.
The accumulated deficit narrowed from roughly negative $1.1B in 2025 to negative $914.8M, suggesting that recent net income has begun to reduce historical losses, though the 2025Q1 reduction from negative $1.1B to negative $505.6M likely reflects a discrete accounting event rather than operating results. Equity itself has fluctuated between $299.4M and $438.8M over the period, which may reflect buybacks offsetting stock-based compensation issuance. Investors should monitor whether equity continues to be consumed by repurchases faster than it is rebuilt through earnings.
Deferred Revenue Flatters Apparent Balance Sheet Strength
According to recent SEC filings, HNGE's $459.2M of deferred revenue represents a large portion of its $574.7M in total liabilities, meaning the liability base is dominated by obligations to customers rather than financial creditors.
While low debt supports the headline leverage picture, the substantial deferred revenue balance means a meaningful share of reported cash is effectively owed to customers for services not yet delivered. This structure may mean that cash of $211.6M overstates free liquidity if contract servicing costs must be funded before revenue is recognized. The analysis suggests that investors should look through headline solvency metrics to assess how much cash is truly unencumbered.